RECOMMENDATION(S):
RESCIND Board action of May 18, 2021 (C.50), which pertained to a purchase order with Thermo Fisher Scientific, Inc.; and APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Department, a Purchase Order with Fisher Scientific, LLC, in an amount not to exceed $1,900,000 for the purchase of reagents and supplies including small equipment and Triage Brain Natriuretic Peptide (BNP) tests for the clinical laboratories at the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, for the period from May 1, 2021 through April 30, 2026.
FISCAL IMPACT:
Approval of this action will result in annual expenditures of up to $1,900,000 over a five-year period and will be funded 100% by Hospital Enterprise Fund I revenues.
|